- Higher white matter extracellular free-water related to cognitive dysfunction in lupus patients 19/09/2021 02:51 Medical News Systemic lupus erythematosus (SLE) is an autoimmune disease in which the immune system attacks the body's own tissues, causing widespread inflammation and damage in the affected organs. It can affect the joints, skin, brain, lungs, kidneys, and blood …
- ACL tears, which often lead to early-adult arthritis, called high school sports 'epidemic' 18/09/2021 14:54 The Journal News - New York Alex Doukas was moving behind the net. A Bronxville girls lacrosse teammate threw her a pass. It was high. Doukas jumped for the ball. So did the John Jay-Cross River defensive player. In the air, they collided, the girl smashing into the outside of Doukas …
- How to stop bone loss from osteoporosis 17/09/2021 13:53 www.madison.com - Wisconsin Stop bone loss from osteoporosis Howard LeWine, M.D., Harvard Health Publishing, The Medicine Cabinet Posted 09/15/2021 at 10:00 am EST Q: I am a 62-year-old woman with osteoporosis. I see advertisements for several different treatments. How does …
- Pharmac funds arthritis drug for Covid-19 amid major stock shortages 17/09/2021 05:21 Stuff Drug-buying agency Pharmac will widen funding for an arthritis drug to treat people hospitalised with Covid-19, but stock shortages mean the drug won’t arrive until January. The immunosuppressive drug, tocilizumab, will be used to treat patients with …
- Middle East Arthritis Foundation announces 2021 webinar series to address various forms of arthritis 16/09/2021 23:05 MENAFN ( MENAFN - Mid-East.Info D)ubai, UAE: The Middle East Arthritis Foundation (MEAF) is back with its signature webinar series from October 10th to October 15th 2021 to observe the World Arthritis Day, a global awareness day held each year on October 12th to …
- Arthritis drug funded to treat Covid-19 – Expert Reaction 16/09/2021 22:37 Scoop Arthritis drug tocilizumab will now be funded to treat patients with moderate to severe cases of Covid-19. The drug is facing massive demand around the world, with its manufacturer Roche no longer able to supply New Zealand with the drug for the next three …
- Rheumatoid Arthritis Drugs Market Size to Reach $62.93 Billion, Growing at a CAGR 2.8% by 2027 16/09/2021 17:38 EIN Presswire Rise in the prevalence of rheumatoid arthritis, surge in geriatric population, and transition from symptom management to slowing the progression of the disease PORTLAND, OR, UNITED STATES, September 16, 2021 /EINPresswire.com/ -- Rheumatoid …
- Menopause Society Issues First Osteoporosis Advice for 10 Years 16/09/2021 16:37 Medscape In the first revision to its guidance on the management of osteoporosis in a decade, The North American Menopause Society (NAMS) has issued an updated position statement addressing evolving evidence on osteoporosis issues ranging from screening and risk …
- Pharmac funds new treatment for rheumatoid arthritis 16/09/2021 04:45 Scoop Thursday, 16 September 2021, 2:47 pm Press Release: PHARMAC Pharmac funds new treatment for rheumatoid arthritis to support people impacted by tocilizumab stock shortage Pharmac has funded upadacitinib tablets as an alternative treatment for New Zealanders …
- American College of Rheumatology Responds to 2022 Medicare Physician Fee Schedule Proposed Rule 16/09/2021 01:06 Newswise Newswise — In comments submitted to the Centers for Medicare and Medicaid Services (CMS), the American College of Rheumatology (ACR) shared its perspective on the CY 2022 Medicare Physician Fee Schedule and Quality Payment Program proposed rule. “We are …
